Dan King
Novartis (United States)(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Peptidase Inhibition and Analysis, Immune Response and Inflammation, Cancer-related Molecular Pathways
Most-Cited Works
- → Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex(2019)249 cited
- → A reassessment of the MAdCAM-1 structure and its role in integrin recognition(2002)22 cited
- → Identification and characterization of ternary complexes consisting of FKBP12, MAPRE1 and macrocyclic molecular glues(2025)5 cited
- → The structural basis of Indisulam-mediated recruitment of RBM39 to the DCAF15-DDB1-DDA1 E3 ligase complex(2019)3 cited
- → Author Correction: Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex(2020)3 cited